Pharma News

Capricor refutes FDA’s DMD deramiocel rejection in public statement

Health Canada approves Medison and Ipsen’s Bylvay to treat ALGS

New Preclinical Data on ART12.11 for the Treatment of Mood and Anxiety Disorders

FDA Continues Focus on Rare Disease Drug Development, Announces Evidence Principles

Tolerance Bio and ZipCode Bio Announce Strategic R&D Collaboration to Advance Targeted Thymus Therapeutics

Novartis snaps up promising ASCVD asset with Tourmaline acquisition

Ionis Pharmaceuticals To Expedite Development Of Rare Neurological Disease Candidate With FDA Breakthrough Status

Epigenic secures $60m financing to advance preclinical assets

Senhwa Biosciences CX-5461 Secures NCI Support to Advance into MYC-Driven Lymphoma, Driving Cross-Cancer and Global Licensing Value

FDA Grants Breakthrough Therapy Designation to Olomorasib With Pembrolizumab for NSCLC

Clene Inc. announces preclinical data showing CNM-Au8 enhances cellular health in Parkinson’s disease models, supporting further clinical development

Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market